Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 37.7 USD 1.02% Market Closed
Market Cap: 329.9m USD
Have any thoughts about
Sanara Medtech Inc?
Write Note

Sanara Medtech Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sanara Medtech Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Sanara Medtech Inc
NASDAQ:SMTI
Net Income (Common)
-$8.4m
CAGR 3-Years
-22%
CAGR 5-Years
-35%
CAGR 10-Years
-9%
Haemonetics Corp
NYSE:HAE
Net Income (Common)
$123.8m
CAGR 3-Years
58%
CAGR 5-Years
13%
CAGR 10-Years
15%
ICU Medical Inc
NASDAQ:ICUI
Net Income (Common)
-$111m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Net Income (Common)
$441.6m
CAGR 3-Years
-16%
CAGR 5-Years
1%
CAGR 10-Years
12%
Lantheus Holdings Inc
NASDAQ:LNTH
Net Income (Common)
$427.6m
CAGR 3-Years
N/A
CAGR 5-Years
65%
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Net Income (Common)
$120m
CAGR 3-Years
40%
CAGR 5-Years
45%
CAGR 10-Years
19%
No Stocks Found

Sanara Medtech Inc
Glance View

Market Cap
329.6m USD
Industry
Health Care

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.

SMTI Intrinsic Value
41.28 USD
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Sanara Medtech Inc's Net Income (Common)?
Net Income (Common)
-8.4m USD

Based on the financial report for Sep 30, 2024, Sanara Medtech Inc's Net Income (Common) amounts to -8.4m USD.

What is Sanara Medtech Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-9%

Over the last year, the Net Income (Common) growth was -2%. The average annual Net Income (Common) growth rates for Sanara Medtech Inc have been -22% over the past three years , -35% over the past five years , and -9% over the past ten years .

Back to Top